ConductScience.org, home

Paper42587147

Rb-driven transcription limits its tumour-suppressive effects in breast cancer.

Watt AC and 23 others. Nature, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Rb-driven transcription limits its tumour-suppressive effects in breast cancer. Papers, record 42587147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42587147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rb-driven transcription limits its tumour-suppressive effects in breast cancer.
PubMed
Journal
Nature
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-10-02
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Watt ACApril Chttps://orcid.org/0000-0002-5145-5334
2Ahn AAntonio
3Blyth CCatherinehttps://orcid.org/0000-0002-6653-1723
4Dixon-Douglas JRJulia R
5Ambani KKrutika
6Coulson RRhiannon
7Taylor MMichaelhttps://orcid.org/0000-0003-1115-5449
8Chan KTKeefe Thttps://orcid.org/0000-0001-6114-3724
9Dietrich CCatherine
10Russ BEBrendan Ehttps://orcid.org/0000-0001-6862-5283
11Ramm SSusanne
12Mahendra CAChristabella A
13Lu KHKun-Hui
14Pires NNichellehttps://orcid.org/0000-0002-0485-2927
15Garcia-Sannicolas JJesushttps://orcid.org/0009-0007-2344-1246
16Voulgaris OOliviahttps://orcid.org/0009-0008-1168-8521
17Nunag SSheena
18Ang CSChing-Seng
19Dawson MAMark Ahttps://orcid.org/0000-0002-5464-5029
20Lim EElgenehttps://orcid.org/0000-0001-8065-8838

Source PubMed

See all 24 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Retinoblastoma ProteinMajor topic
Transcription, GeneticMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Genes, Tumor SuppressorMajor topic
Humans
Female
Animals
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6
Promoter Regions, Genetic
Receptors, Estrogen
Cell Line, Tumor
Mice
Phosphorylation
Enhancer Elements, Genetic
Cell Proliferation

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed

Source NIH RePORTER

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19545246Rb binds c-Jun and activates transcription.EMBO J1998https://conductscience.org/library/papers/9545246PubMed
21321348Retinoblastoma protein switches the E2F site from positive to negative element.Nature1992https://conductscience.org/library/papers/1321348PubMed
318650841Cellular mechanisms of tumour suppression by the retinoblastoma gene.Nat Rev Cancer2008https://conductscience.org/library/papers/18650841PubMed
429483214Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer.Mol Cancer Ther2018https://conductscience.org/library/papers/29483214PubMed
534433817Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.Nat Commun2021https://conductscience.org/library/papers/34433817PubMed
611484059Rb targets histone H3 methylation and HP1 to promoters.Nature2001https://conductscience.org/library/papers/11484059PubMed
737648594Patterns in the tapestry of chromatin-bound RB.Trends Cell Biol2024https://conductscience.org/library/papers/37648594PubMed
820513432Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.Mol Cell2010https://conductscience.org/library/papers/20513432PubMed
924263090Target analysis by integration of transcriptome and ChIP-seq data with BETA.Nat Protoc2013https://conductscience.org/library/papers/24263090PubMed
1025501126CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.Clin Cancer Res2015https://conductscience.org/library/papers/25501126PubMed
1134723319The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.Nucleic Acids Res2022https://conductscience.org/library/papers/34723319PubMed
1235085776SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets.Genomics Proteomics Bioinformatics2022https://conductscience.org/library/papers/35085776PubMed
131531329The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.Genes Dev1992https://conductscience.org/library/papers/1531329PubMed
1442587147Rb-driven transcription limits its tumour-suppressive effects in breast cancer.Nature2026https://conductscience.org/library/papers/42587147PubMed
1531353221Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.Cell2019https://conductscience.org/library/papers/31353221PubMed
1630101006An end to end workflow for differential gene expression using Affymetrix microarrays.F1000Res2016https://conductscience.org/library/papers/30101006PubMed
1734544752INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.Cancer Discov2022https://conductscience.org/library/papers/34544752PubMed
1826977878Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.Cancer Cell2016https://conductscience.org/library/papers/26977878PubMed
1929073143BBMerge - Accurate paired shotgun read merging via overlap.PLoS One2017https://conductscience.org/library/papers/29073143PubMed
2024227677featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.Bioinformatics2014https://conductscience.org/library/papers/24227677PubMed

See all 66 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42706313The secret life of a cell-cycle gatekeeper of breast cancer.Nature2026https://conductscience.org/library/papers/42706313PubMed
42587147Rb-driven transcription limits its tumour-suppressive effects in breast cancer.Nature2026https://conductscience.org/library/papers/42587147PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
KDM5A5927PubTator's text mininghttps://conductscience.org/library/genes/5927NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42587147

GET https://conductscience.org/api/papers/v1/42587147/authors?page=2